- Home
- AOD vs CNTA Comparison
AOD vs CNTA Comparison
Compare AOD & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AOD | CNTA |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United Kingdom | United Kingdom |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 970.0M | 2.3B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AOD | CNTA |
|---|---|---|
| Price | $9.68 | $26.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $37.70 |
| AVG Volume (30 Days) | 423.5K | ★ 1.8M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 12.95% | N/A |
| EPS Growth | ★ 213.63 | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $72,962,082.00 | $15,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.44 | ★ N/A |
| Revenue Growth | N/A | ★ 118.88 |
| 52 Week Low | $6.99 | $9.60 |
| 52 Week High | $9.14 | $30.58 |
Technical Indicators
Market Signals| Indicator | AOD | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 57.76 | 45.51 |
| Support Level | $9.63 | $28.43 |
| Resistance Level | $9.74 | $30.02 |
| Average True Range (ATR) | 0.08 | 1.34 |
| MACD | 0.02 | -0.40 |
| Stochastic Oscillator | 80.69 | 18.64 |
Price Performance
Historical ComparisonAbout AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.